Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report

BACKGROUND: Checkpoints inhibitors (CPIs) are increasingly used for the treatment of several malignancies. The most common side effects are Immune Related Adverse Events, while infectious complications are rare, especially cerebral nocardiosis. CASE PRESENTATION: Here, we report the first clinical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Petitgas, Paul, Lesouhaitier, Mathieu, Boukthir, Sarrah, Cattoir, Vincent, Tattevin, Pierre, Bénézit, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962086/
https://www.ncbi.nlm.nih.gov/pubmed/35351017
http://dx.doi.org/10.1186/s12879-022-07288-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962086/
https://www.ncbi.nlm.nih.gov/pubmed/35351017
http://dx.doi.org/10.1186/s12879-022-07288-4

Ejemplares similares